AAAAAA

   
Results: 1-10 |
Results: 10
MITOXANTRONE, VINBLASTINE, AND LOMUSTINE (CCNU) (MVC) - A HIGHLY-ACTIVE REGIMEN FOR ADVANCED AND POOR-PROGNOSIS HODGKINS-DISEASE
Authors: WIERNIK PH DUTCHER JP EINZIG AI SPARANO J FRANK M FRIEDENBERG W
Citation: Ph. Wiernik et al., MITOXANTRONE, VINBLASTINE, AND LOMUSTINE (CCNU) (MVC) - A HIGHLY-ACTIVE REGIMEN FOR ADVANCED AND POOR-PROGNOSIS HODGKINS-DISEASE, The cancer journal from Scientific American, 4(4), 1998, pp. 254-260
DETERMINATION AND VALIDATION OF A PREDICTIVE MODEL FOR CLOSTRIDIUM-DIFFICILE DIARRHEA IN HOSPITALIZED ONCOLOGY PATIENTS
Authors: HORNBUCKLE K CHAK A LAZARUS HM COOPER GS KUTTEH LA GUCALP R CARLISLE PS SPARANO J PARKER P SALATA RA
Citation: K. Hornbuckle et al., DETERMINATION AND VALIDATION OF A PREDICTIVE MODEL FOR CLOSTRIDIUM-DIFFICILE DIARRHEA IN HOSPITALIZED ONCOLOGY PATIENTS, Annals of oncology, 9(3), 1998, pp. 307-311
PROSPECTIVE RANDOMIZED TRIAL OF LISOFYLLINE FOR THE PREVENTION OF TOXICITIES OF HIGH-DOSE INTERLEUKIN-2 THERAPY IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA
Authors: MARGOLIN K ATKINS M SPARANO J SOSMAN J WEISS G LOTZE M DOROSHOW J MIER J OBOYLE K FISHER R CAMPBELL E RUBIN J FEDERIGHI D BURSTEN S
Citation: K. Margolin et al., PROSPECTIVE RANDOMIZED TRIAL OF LISOFYLLINE FOR THE PREVENTION OF TOXICITIES OF HIGH-DOSE INTERLEUKIN-2 THERAPY IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA, Clinical cancer research, 3(4), 1997, pp. 565-572
CHEMOTHERAPY FOR AIDS-RELATED LYMPHOMAS
Authors: SPARANO J
Citation: J. Sparano, CHEMOTHERAPY FOR AIDS-RELATED LYMPHOMAS, The New England journal of medicine, 337(16), 1997, pp. 1173-1173
2 SEQUENTIAL PROSPECTIVE, MULTIINSTITUTIONAL PHASE-II CLINICAL-TRIALSOF MITOGUAZONE (MGBG) IN REFRACTORY OR RELAPSED AIDS-RELATED LYMPHOMA
Authors: LEVINE AM GILES F KAPLAN L SPARANO J SCADDEN D LUSKEY B NORTHFELT D THOMMAS J ANDERSON LJJ ESPINA B TESSMAN D VONHOFF D
Citation: Am. Levine et al., 2 SEQUENTIAL PROSPECTIVE, MULTIINSTITUTIONAL PHASE-II CLINICAL-TRIALSOF MITOGUAZONE (MGBG) IN REFRACTORY OR RELAPSED AIDS-RELATED LYMPHOMA, Blood, 86(10), 1995, pp. 1512-1512
INTRODUCTION TO BONE-MARROW TRANSPLANT SYMPOSIUM HELD AT THE ALBERT-EINSTEIN-CANCER-CENTER AT BRONX, NY, USA, MARCH 23 TO 25, 1994
Authors: GUCALP R SPARANO J DUTCHER JP WIERNIK PH
Citation: R. Gucalp et al., INTRODUCTION TO BONE-MARROW TRANSPLANT SYMPOSIUM HELD AT THE ALBERT-EINSTEIN-CANCER-CENTER AT BRONX, NY, USA, MARCH 23 TO 25, 1994, Medical oncology, 11(2), 1994, pp. 31-33
INTERLEUKINS IN CANCER-THERAPY - RATIONALE AND CURRENT STATUS
Authors: OLEKSOWICZ L SPARANO J OBOYLE K VENKATRAJ U WIERNIK PH DUTCHER JP
Citation: L. Oleksowicz et al., INTERLEUKINS IN CANCER-THERAPY - RATIONALE AND CURRENT STATUS, CLINICAL IMMUNOTHERAPEUTICS, 1(4), 1994, pp. 271-281
A DISTINCT COAGULOPATHY ASSOCIATED WITH INTERLEUKIN-2 THERAPY
Authors: OLEKSOWICZ L STRACK M DUTCHER JP SUSSMAN I CALIENDO G SPARANO J WIERNIK PH
Citation: L. Oleksowicz et al., A DISTINCT COAGULOPATHY ASSOCIATED WITH INTERLEUKIN-2 THERAPY, British Journal of Haematology, 88(4), 1994, pp. 892-894
CONCURRENT IL-6 PLUS G-CSF TO SUPPORT DOSE-INTENSIFIED CYCLOPHOSPHAMIDE DOXORUBICIN (CD) - POSSIBLE ACCELERATION OF HEMATOLOGIC RECOVERY FROM CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA
Authors: DEMETRI GD HAYES DF MERICA EA CAP B SPARANO J
Citation: Gd. Demetri et al., CONCURRENT IL-6 PLUS G-CSF TO SUPPORT DOSE-INTENSIFIED CYCLOPHOSPHAMIDE DOXORUBICIN (CD) - POSSIBLE ACCELERATION OF HEMATOLOGIC RECOVERY FROM CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA, Blood, 84(10), 1994, pp. 10000029-10000029
SURVIVAL AFTER PHASE-II TREATMENT OF ADVANCED RENAL-CELL CARCINOMA WITH TAXOL OR HIGH-DOSE INTERLEUKIN-2
Authors: WALPOLE ET DUTCHER JP SPARANO J GUCALP R EINZIG A PAIETTA E CIOBANU N GRIMA K CALIENDO G CAVASOTTO G WIERNIK PH
Citation: Et. Walpole et al., SURVIVAL AFTER PHASE-II TREATMENT OF ADVANCED RENAL-CELL CARCINOMA WITH TAXOL OR HIGH-DOSE INTERLEUKIN-2, Journal of immunotherapy with emphasis on tumor immunology, 13(4), 1993, pp. 275-281
Risultati: 1-10 |